Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Human BCMA targeted T Cells Injection
DRUG
2 trials
Sponsors
Hrain Biotechnology Co., Ltd.
Conditions
Multiple Myeloma
Phase 1
Human BCMA Targeted T Cells Injection Therapy for BCMA-positive Relapsed/Refractory Multiple Myeloma
NCT04003168
Hrain Biotechnology Co., Ltd.
Multiple Myeloma
Start: 2019-07-01
End: 2024-07-31
Target: 18
Updated: 2021-03-01
Phase 2
Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM
Recruiting
NCT05594797
Hrain Biotechnology Co., Ltd.
Multiple Myeloma
Start: 2022-07-12
End: 2027-07-31
Target: 100
Updated: 2022-12-09
Related Papers
A simple and effective method to purify and activate T cells for successful generation of chimeric antigen receptor T (CAR-T) cells from patients with high monocyte count
Journal of Translational Medicine
2022-12-19
19 citations